Robin Shane Readnour

Insider Reports History

Location
Nashville, TN
Signature
/s/ Lucy Day, Attorney-in-Fact for Robin Shane Readnour
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robin Shane Readnour:

Company Role Class Num Shares Value Price $ Report Date Ownership
AN2 Therapeutics, Inc. Director Stock Option (Right to Buy) 20,400 20 Feb 2026 Direct

Insider Reports Filed by Robin Shane Readnour

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ANTX AN2 Therapeutics, Inc. 20 Feb 2026 1 $0 4 Director 23 Feb 2026, 16:29
ANTX AN2 Therapeutics, Inc. 22 May 2025 1 $0 4 Director 23 May 2025, 17:04
ANTX AN2 Therapeutics, Inc. 19 Dec 2024 1 $0 4 Director 23 Dec 2024, 18:32
ANTX AN2 Therapeutics, Inc. 06 Dec 2024 6 +$86,708 4 Director 10 Dec 2024, 20:46
ANTX AN2 Therapeutics, Inc. 26 Nov 2024 4 +$105,685 4 Director 27 Nov 2024, 19:07
ANTX AN2 Therapeutics, Inc. 19 Nov 2024 4 +$213,128 4 Director 21 Nov 2024, 18:00
ANTX AN2 Therapeutics, Inc. 19 Jun 2024 1 $0 4 Director 21 Jun 2024, 18:22
ANTX AN2 Therapeutics, Inc. 12 Jan 2024 2 -$31,229 4 Director 17 Jan 2024, 17:03
ANTX AN2 Therapeutics, Inc. 10 Jan 2024 2 -$80,443 4 Director 12 Jan 2024, 17:08
ANTX AN2 Therapeutics, Inc. 07 Jun 2023 1 $0 4 Director 09 Jun 2023, 20:33
ANTX AN2 Therapeutics, Inc. 12 May 2022 1 $0 4 Director 16 May 2022, 21:25
ANTX AN2 Therapeutics, Inc. 29 Mar 2022 10 +$2,300,010 4 Director 31 Mar 2022, 20:15
ANTX AN2 Therapeutics, Inc. 24 Mar 2022 0 $0 3 Director 24 Mar 2022, 21:21